Efficacy Comparison of Ivermectin 1% Topical Cream Associated With Doxycycline 40 mg Modified Release (MR) Capsules Versus Ivermectin 1% Topical Cream Associated With Placebo in the Treatment of Severe Rosacea

Trial Profile

Efficacy Comparison of Ivermectin 1% Topical Cream Associated With Doxycycline 40 mg Modified Release (MR) Capsules Versus Ivermectin 1% Topical Cream Associated With Placebo in the Treatment of Severe Rosacea

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 25 Apr 2018

At a glance

  • Drugs Doxycycline (Primary) ; Ivermectin
  • Indications Rosacea
  • Focus Therapeutic Use
  • Acronyms ANSWER
  • Sponsors Galderma
  • Most Recent Events

    • 22 Apr 2018 This trial has been completed in Hungary (End date: 2018-01-23) according to European Clinical Trials Database.
    • 18 Apr 2018 This trial has been completed in Germany, according to European Clinical Trials Database.
    • 11 Jan 2018 Planned primary completion date changed from 15 Nov 2017 to 15 Feb 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top